Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: Results from the United States multicenter trial

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 4, 2008, Pages 1238-1245

  Mogul, Harriette R ^a   Lee, Phillip D K ^b,e   Whitman, Barbara Y ^c   Zipf, William B ^d   Frey, Michael ^a   Myers, Susan ^c   Cahan, Mindy ^b   Pinyerd, Belinda ^d   Louis Southren, A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e EMD SERONO INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; LIOTHYRONINE;

ADULT; ANKLE EDEMA; ARTICLE; BODY COMPOSITION; BODY FAT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERABILITY; FEMALE; GENOTYPE; GROWTH HORMONE DEFICIENCY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; LEAN BODY WEIGHT; LIOTHYRONINE BLOOD LEVEL; LONG TERM CARE; MALE; MULTICENTER STUDY; MYALGIA; PATIENT MONITORING; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UNITED STATES;

EID: 42049095284     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2212     Document Type: Article

References (34)

1. Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M 1996 Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 9:393-400
2. Lindgren AC, Hagenas L, Muller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzen EM 1997 Effects of growth hormone treatment on growth and body composition in Prader-Willi syndrome: a preliminary report. The Swedish National Growth Hormone Advisory Group. Acta Paediatr Suppl 423:60-62
3. Davies PS, Evans S, Broomhead S, Clough H, Day JM, Laidlaw A, Barnes ND 1998 Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome. Arch Dis Child 78:474-476
4. Carrel AL, Myers SE, Whitman BY, Allen DB 1999 Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J Pediatr 134:215-221
5. Carrel AL, Myers SE, Whitman BY, Allen DB 2002 Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab 87:1581-1585
6. Eiholzer U, Weber R, Stutz K, Steinert H 1997 Effect of 6 months of growth hormone treatment in young children with Prader-Willi syndrome. Acta Paediatr Suppl 423:66-68
7. Haag AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH 2003 Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 88:2206-2212
8. Partsch CJ, Lammer C, Gillessen-Kaesbach G, Pankau R 2000 Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion. Growth Horm IGF Res 10(Suppl B):S81-S85
9. Ritzen EM, Lindgren AC, Hagenas L, Marcus C, Muller J, Blichfeldt S 1999 Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group. J Pediatr Endocrinol Metab 12(Suppl 1):345-349
10. Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB 2007 Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 143:443-448
11. Carrel A, Lee PD, Mogul H 2006 Growth hormone and Prader-Willi syndrome. In: Butler J, Lee PD, Whitman B, eds. Management of Prader-Willi Syndrome. 3rd ed. New York: Springer; 201-241
12. Hoybye C, Hilding A, Jacobsson H, Thoren M 2003 Growth hormone treatment improves body composition in adults with Prader-Willi syndrome. Clin Endocrinol (Oxf) 58:653-661
13. Jorgensen JO, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE, Christiansen JS 1989 Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab 69:1127-1132
14. Jorgensen JO, Moller J, Skakkebaek NE, Weeke J, Christiansen JS 1992 Thyroid function during growth hormone therapy. Horm Res 38(Suppl 1):63-67
15. Jorgensen JO, Moller J, Laursen T, Orskov H, Christiansen JS, Weeke J 1994 Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf) 41:609-614
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
18. Hoybye C 2004 Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Growth Horm IGF Res 14:1-15
19. Hoybye C 2007 Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome. Acta Paediatr 96:410-413
20. Gotherstrom G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J 2007 A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab 92:1442-1445
21. Lindgren AC, Hagenas L, Muller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzen EM 1998 Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr 87:28-31
22. Carrel AL, Myers SE, Whitman BY, Allen DB 2001 Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent. J Pediatr Endocrinol Metab 14:1097-1105
23. Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE 1983 The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Medicine (Baltimore) 62:59-80
24. Schuster DP, Osei K, Zipf WB 1996 Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism 45:1514-1520
25. Eiholzer U, Stutz K, Weinmann C, Torresani T, Molinari L, Prader A 1998 Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome. Eur J Pediatr 157:890-893
26. Greenswag LR 1987 Adults with Prader-Willi syndrome: a survey of 232 cases. Dev Med Child Neurol 29:145-152
27. Burman P, Ritzen EM, Lindgren AC 2001 Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 22:787-799
28. Butler MG, Theodoro M, Skouse JD 2007 Thyroid function studies in Prader-Willi syndrome. Am J Med Genet A 143:488-492
29. Tauber M, Barbeau C, Jouret B, Pienkowski C, Malzac P, Moncla A, Rochiccioli P 2000 Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children. Horm Res 53:279-287
30. Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC 2007 Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Clin Endocrinol (Oxf) 67:449-456
31. 3 and TBG in hypopituitary patients. Acta Endocrinol (Copenh) 96:475-479
32. Agha A, Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, Grossman AB, Monson JP 2007 Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf) 66:72-77
33. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-2533
34. Hoybye C, Thoren M, Bohm B 2005 Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome. J Intellect Disabil Res 49:245-252